Found 0 matching trials
Predictors of Antidepressant Response
PHASE4Major depression is a highly prevalent, frequently debilitating illness tha...
Location
Department of Psychiatry
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
PHASE2This study will determine whether combination treatment driven by patient c...
Location
New York State Psychiatric Institute
Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
NARATIONALE: Contingency management is a behavioral treatment approach that p...
Location
Tobacco Control Research Branch
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
PHASE1The purpose of this study is to investigate whether Lorexys is effective an...
Location
Robert Taylor Segraves, MD, PhD
Effect of Bupropion on Seizure Threshold in Depressed Patients
PHASE4The purpose of the study is to examine the effect of bupropion on seizure t...
Location
Duke University Medical Center
Maintaining Abstinence in Chronic Cigarette Smokers - 1
PHASE2The purpose of this study is to evaluate the extended pharmacological and p...
Location
University California, San Francisco
Lethargic Depression Study
PHASE3This is a study of Major Depressive Disorder (MDD) in patients with decreas...
Location
GSK Investigational Site
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
PHASE3The primary objective of this study is to evaluate the efficacy of extended...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Effects of Bupropion in Depression
NAThis study will investigate the role of dopaminergic neural systems in the ...
Location
University of Oxford
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
PHASE3This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)